title: Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route.
abstract: Botulinum toxin is a highly potent oral and inhalation poison, which means that the toxin must have an efficient mechanism for penetration of epithelial barriers. To date, three models for toxin passage across epithelial barriers have been proposed: (i) the toxin itself undergoes binding and transcytosis; (ii) an auxiliary protein, HA35, transports toxin from the apical to the basal side of epithelial cells; and (iii) an auxiliary protein, HA35, acts on the basal side of epithelial cells to disrupt tight junctions, and this permits paracellular flux of toxin. These models were evaluated by studying toxin absorption following inhalation exposure in mice. Three types of experiments were conducted. In the first, the potency of pure neurotoxin was compared with that of progenitor toxin complex, which contains HA35. The results showed that the rate and extent of toxin absorption, as well as the potency of absorbed toxin, did not depend upon, nor were they enhanced by, the presence of HA35. In the second type of experiment, the potencies of pure neurotoxin and progenitor toxin complex were compared in the absence or presence of antibodies on the apical side of epithelial cells. Antibodies directed against the neurotoxin protected against challenge, but antibodies against HA35 did not. In the final type of experiment, the potency of pure neurotoxin and toxin complex was compared in animals pretreated to deliver antibodies to the basal side of epithelial cells. Once again, antibodies directed against the neurotoxin provided resistance to challenge, but antibodies directed against HA35 did not. Taken collectively, the data indicate that the toxin by itself is capable of crossing epithelial barriers. The data do not support any hypothesis in which HA35 is essential for toxin penetration of epithelial barriers.
authors.affiliation: Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
authors.forename: Fetweh H
authors.initials: FH
authors.lastname: Al-Saleem
authors.forename: Denise M
authors.initials: DM
authors.lastname: Ancharski
authors.forename: Suresh G
authors.initials: SG
authors.lastname: Joshi
authors.forename: M
authors.initials: M
authors.lastname: Elias
authors.forename: Ajay
authors.initials: A
authors.lastname: Singh
authors.forename: Zidoon
authors.initials: Z
authors.lastname: Nasser
authors.forename: Lance L
authors.initials: LL
authors.lastname: Simpson
mesh_terms: D000042:Absorption; D000280:Administration, Inhalation; D000818:Animals; D001692:Biological Transport; D001905:Botulinum Toxins / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics* / Q000506:poisoning; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics* / Q000506:poisoning; D004195:Disease Models, Animal; D004847:Epithelial Cells / Q000378:metabolism*; D005260:Female; D051379:Mice; D011817:Rabbits; D057900:Transcytosis
chemical_list: D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; C096326:botulinum toxin type E